updated PO files

diff --git a/open-source-biologist.en.po b/open-source-biologist.en.po
index 1cf95c10a412f0035a8a4acdf4242644c99888e0..38eefe8e026b19c9e277b9822f2e91e5417d44b5 100644 (file)
--- a/open-source-biologist.en.po
+++ b/open-source-biologist.en.po
@@ -7,7 +7,7 @@
 msgid ""
 msgstr ""
 "Project-Id-Version: PACKAGE VERSION\n"
-"POT-Creation-Date: 2020-06-15 07:55+0000\n"
+"POT-Creation-Date: 2020-06-15 08:46+0000\n"
 "PO-Revision-Date: YEAR-MO-DA HO:MI+ZONE\n"
 "Last-Translator: FULL NAME <EMAIL@ADDRESS>\n"
 "Language-Team: LANGUAGE <LL@li.org>\n"
@@ -58,25 +58,28 @@ msgid ""
 "On April 2013, I started a new development cycle as the leader of the "
 "Genomics Miniaturization Technology Unit at RIKEN Center for Life Sciences, "
 "Division of Genomics Technology, to expand this work on single cells "
-"following a **population transcriptomics** approach (Plessy et al., 2013) "
-"focused on sampling the largest possible number of cells. In our ongoing "
-"developments, we have reached **single-cell and single molecule resolution** "
-"through the introduction of transposase fragmentation and unique molecular "
-"identifiers (Poulain et al., 2017). The protocol exists in two versions, one "
-"for FACS-isolated cells, and one for the Fluidigm C1 platform (Kouno et al., "
-"2019)."
+"following a **population transcriptomics** approach ([Plessy and coll., 2013]"
+"(https://pubmed.gov/23281054)) focused on sampling the largest possible "
+"number of cells. In our ongoing developments, we have reached **single-cell "
+"and single molecule resolution** through the introduction of transposase "
+"fragmentation and unique molecular identifiers ([Poulain and coll., 2017]"
+"(https://pubmed.gov/28349422)). The protocol exists in two versions, one for "
+"FACS-isolated cells, and one for the Fluidigm C1 platform ([Kouno and coll., "
+"2019](https://pubmed.gov/30664627))."
 msgstr ""
 
 #. type: Plain text
 msgid ""
 "I have complemented my work on CAGE with the development of a gene-centred "
-"technique for detecting promoters, termed Deep-RACE (Olivarius et al., 2009, "
-"Plessy et al., 2012), which we used to validate our discovery of the "
-"pervasive expression of retrotransposons detected by CAGE (Faulkner et al., "
-"2009). To study transcription start activity at nucleotide resolution in "
-"zebrafish transfected with chimeric transgenes containing a copy of an "
-"endogenous promoter, I combined Deep-RACE, CAGE and paired-end sequencing in "
-"a technology that we called “Single-Locus CAGE” (Haberle et al., 2014). With "
+"technique for detecting promoters, termed Deep-RACE ([Olivarius and coll., "
+"2009](https://pubmed.gov/19317658), [Plessy and coll., 2012](http://dx.doi."
+"org/10.1002/9783527644582.ch4)), which we used to validate our discovery of "
+"the pervasive expression of retrotransposons detected by CAGE ([Faulkner and "
+"coll., 2009](https://pubmed.gov/19377475)). To study transcription start "
+"activity at nucleotide resolution in zebrafish transfected with chimeric "
+"transgenes containing a copy of an endogenous promoter, I combined Deep-"
+"RACE, CAGE and paired-end sequencing in a technology that we called “Single-"
+"Locus CAGE” ([Haberle and coll., 2014](https://pubmed.gov/24531765)). With "
 "my contributions related to CAGE development and analysis, I have been a "
 "**member of the FANTOM consortium** since FANTOM3."
 msgstr ""
@@ -85,7 +88,7 @@ msgstr ""
 msgid ""
 "Together with my colleagues at RIKEN and collaborators in the field of "
 "neuroscience, I have applied nanoCAGE to the study of single neuron cell "
-"types, for instance the **olfactory neurons** (Plessy et al., 2012), or in "
+"types, for instance the **olfactory neurons** ([Plessy et al., 2012), or in "
 "dopaminergic cells, where we could demonstrate the expression of haemoglobin "
 "in the midbrain (Biagioli et al., 2009). We are also exploring the sub-"
 "cellular localisation of RNA in **Purkinje neurons** (Kratz et al., 2014), "